Citation Impact
Citing Papers
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
2005
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates
2003
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Head and neck squamous cell carcinoma
2020 Standout
Nasopharyngeal carcinoma
2005 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid
2014
Carcinoma of the nasopharynx: factors affecting prognosis
1992
Microsatellite Instability in Colorectal Cancer
2010 Standout
Chromosomal Aberration Patterns Differ in Subtypes of Primary Cutaneous B Cell Lymphomas
2004
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Nasopharyngeal carcinoma: A medical oncology viewpoint. The Gustave Roussy experience
1990
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
1998 Standout
Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c
2016 StandoutNobel
Staging and follow-up of nasopharyngeal carcinoma: Magnetic resonance imaging versus computerized tomography
1995
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Head and neck cancer
2008 Standout
A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients
2002
Nasopharyngeal carcinoma
2019 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.
1998
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials
2001
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Treatment of head and neck cancer: the role of chemotherapy
1996
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation
2005
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
2015 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
MLPA and MAPH: New techniques for detection of gene deletions
2004
Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis
2005
Genetics of childhood cataract
2004
Long-Term Prognostic Effects of Plasma Epstein-Barr Virus DNA by Minor Groove Binder-Probe Real-Time Quantitative PCR on Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemoradiotherapy
2007
Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Nasopharyngeal carcinoma
2015 Standout
Male breast cancer
2006 Standout
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
1991
PTEN hamartoma tumor syndromes
2008 Standout
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy
2012
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
TGFβ in Cancer
2008 Standout
Head and Neck Cancer
1993 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5‐fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma
2004
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
2000
Another way to estimate outcome of advanced nasopharyngeal carcinoma—is concurrent chemoradiotherapy adequate?
2004
MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations
2009
Large Genomic Rearrangement in BRCA1 and BRCA2 and Clinical Characteristics of Men with Breast Cancer in the United States
2007
Comparative genomic hybridization analysis of primary cutaneous B‐cell lymphomas: Identification of common genomic alterations in disease pathogenesis
2002
Head and Neck Cancer
2001 Standout
Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types
1999
Epidemiology of lymphomas
2000
Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety
2005
Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial
2002
Head and Neck Cancer
2020 Standout
Gene expression changes during cataract progression in Sparc null mice: differential regulation of mouse globins in the lens.
2004 StandoutNobel
Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study
2004
Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials
2005
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma
2013
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival
2003
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
2001
Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Identification of molecular apocrine breast tumours by microarray analysis
2005
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
2018
Accelerated Concomitant Boost Radiotherapy and Chemotherapy for Advanced Nasopharyngeal Carcinoma
2001
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
2005 Standout
Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials
2010
Works of Annick Rossi being referenced
Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation
2006
Complete germline deletion of the STK11 gene in a family with Peutz–Jeghers syndrome
2004
Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.
1988
Refinement of the NHS locus on chromosome Xp22.13 and analysis of five candidate genes
2002
Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families
2002
Prognostic value of chromosomal abnormalities in follicular lymphoma
1994